In tune with the flavour of the month, The Vaccine Group (TVG; a 17% holding for Frontier IP) has announced updates on its novel animal vaccines, including the start of a research project on COVID-19, but also the validation of its technology, and the initiation of animal trials for Bovine Tuberculosis (bTB) and African Swine Fever (ASF). Whilst we are aware of 35 vaccines and therapies in development, this is the first one we know of targeting the animal host population. COVID-19 developments a ....
13 Mar 2020
The Vaccine Group; Intriguing COVID-19 and other key vaccine updates
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
The Vaccine Group; Intriguing COVID-19 and other key vaccine updates
Frontier IP Group Plc (FIPP:LON) | 38.5 -0.8 (-4.9%) | Mkt Cap: 21.6m
- Published:
13 Mar 2020 -
Author:
Edward Thomason -
Pages:
4
In tune with the flavour of the month, The Vaccine Group (TVG; a 17% holding for Frontier IP) has announced updates on its novel animal vaccines, including the start of a research project on COVID-19, but also the validation of its technology, and the initiation of animal trials for Bovine Tuberculosis (bTB) and African Swine Fever (ASF). Whilst we are aware of 35 vaccines and therapies in development, this is the first one we know of targeting the animal host population. COVID-19 developments a ....